Rebecca Begley has an impressive career history in the pharmaceutical industry, with experience in various roles including VP, Program and Alliance Management at Terns Pharmaceuticals, Director of Clinical Pharmacology at Gilead Sciences, and Project Manager at KAI Pharmaceuticals. Rebecca holds a Ph.D. in Molecular Pharmacology from Stanford University, where Rebecca also completed their undergraduate studies at Barnard College. Rebecca's expertise and background make their a highly qualified professional in the field.